首页> 美国卫生研究院文献>other >Anxiety and depression symptoms as risk factors for non-adherence to antiretroviral therapy in Brazil
【2h】

Anxiety and depression symptoms as risk factors for non-adherence to antiretroviral therapy in Brazil

机译:焦虑和抑郁症状是巴西不坚持抗逆转录病毒疗法的危险因素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Depression and anxiety are common among HIV-infected people and rank among the strongest predictors of non-adherence to antiretroviral therapy (ART). This longitudinal study aimed to assess whether symptoms of anxiety and depression are predictors of non-adherence among patients initiating ART at two public referral centers (n=293) in Belo Horizonte, Brazil. Prevalence of severe anxiety and depression symptoms before starting ART was 12.6% and 5.8%, respectively. Severe anxiety was a predictor of non-adherence to ART during follow-up period (RH=1.87; 95% CI=1.14–3.06) adjusted for low education, unemployment, alcohol use in the last month and symptoms of AIDS; while a history of injection drug use had borderline statistical significance with non-adherence. These findings suggest that using a brief screening procedure to assess anxiety and depression symptoms before initiating ART help identify individuals for interventions to improve adherence and quality of life.
机译:抑郁和焦虑在受HIV感染的人群中很常见,并且是不坚持抗逆转录病毒疗法(ART)的最强预测指标之一。这项纵向研究旨在评估在巴西贝洛哈里桑塔的两个公共转诊中心(n = 293)发起抗逆转录病毒治疗的患者中,焦虑和抑郁症状是否是非依从性的预测因素。开始接受抗逆转录病毒治疗前,严重焦虑和抑郁症状的患病率分别为12.6%和5.8%。严重焦虑是随访期间未坚持抗逆转录病毒疗法的一项预测指标(RH = 1.87; 95%CI = 1.14–3.06),这是根据低学历,失业,最近一个月的饮酒和艾滋病症状而调整的;而注射毒品的使用史则具有统计学上的不依从性的临界值。这些发现表明,在开始抗逆转录病毒治疗之前使用简短的筛查程序评估焦虑和抑郁症状有助于确定个体,以进行干预以改善依从性和生活质量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号